Nektar Therapeutics
NKTR
#4629
Rank
NZ$3.53 B
Marketcap
NZ$123.19
Share price
-1.54%
Change (1 day)
460.52%
Change (1 year)

Nektar Therapeutics (NKTR) - Total assets

Total assets on the balance sheet as of December 2025 : NZ$0.48 Billion

According to Nektar Therapeutics 's latest financial reports the company's total assets are NZ$0.48 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31NZ$0.48 B-10.13%
2024-12-31NZ$0.53 B-14.4%
2023-12-31NZ$0.62 B-43.76%
2022-12-31NZ$1.11 B-31.57%
2021-12-31NZ$1.63 B-23.31%
2020-12-31NZ$2.13 B-27.36%
2019-12-31NZ$2.93 B-8.41%
2018-12-31NZ$3.20 B347.38%
2017-12-31NZ$0.71 B-12.75%
2016-12-31NZ$0.82 B12.72%
2015-12-31NZ$0.72 B29.26%
2014-12-31NZ$0.56 B6.59%
2013-12-31NZ$0.52 B-12.62%
2012-12-31NZ$0.60 B-22.14%
2011-12-31NZ$0.77 B15.03%
2010-12-31NZ$0.67 B-14.74%
2009-12-31NZ$0.79 B-17.97%
2008-12-31NZ$0.96 B2.04%
2007-12-31NZ$0.94 B-13.18%
2006-12-31NZ$1.09 B-13.19%
2005-12-31NZ$1.25 B20.32%
2004-12-31NZ$1.04 B10.03%
2003-12-31NZ$0.94 B-18.14%
2002-12-31NZ$1.15 B-27.86%
2001-12-31NZ$1.60 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$345.78 B 70,943.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.32 B 74,135.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$157.23 B 32,205.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$34.81 B 7,052.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$237.57 B 48,709.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$198.00 B 40,581.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.35 B-28.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$4.31 B 786.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland